Loongson Technology Corporation (688047.SH) has had its application for issuing A-shares to specific individuals accepted by the Shanghai Stock Exchange.
Longxin Zhongke (688047.SH) announced that on August 14, 2026, it received a notification from the Shanghai Stock Exchange (referred to as "SSE") regarding the acceptance of the application for issuing securities by Longxin Zhongke Technology Co., Ltd. for its listing on the Sci-Tech Innovation Board. The SSE verified the prospectus and relevant application documents submitted by the company in accordance with relevant regulations and determined that the application documents were complete and met the legal requirements, deciding to accept the application and conduct the review in accordance with the law.
Loongson Technology Corporation (688047.SH) announced that it received a notice from the Shanghai Stock Exchange (referred to as "SSE") on August 14, 2026, regarding the acceptance of Loongson Technology Corporation's application for the issuance of securities for the Sci-Tech Innovation Board. The SSE verified the offering memorandum and related application documents submitted by the company in accordance with relevant regulations, deemed the application documents complete and in legal form, and decided to accept the application for review in accordance with the law.
Related Articles

Guangxi Fenglin Wood Industry Group (601996.SH): Received tax matter notice requiring the payment of approximately 27 million yuan in taxes.

Zhejiang Yonghe Refrigerant (605020.SH) has had its application for the issuance of convertible bonds to unspecified recipients accepted by the Shanghai Stock Exchange.

CanSino Biologics Inc. (688185.SH): Application for Drug Registration of Adsorbed Acellular Combined Vaccine for Diphtheria, Tetanus, and Whooping Cough (Five Components) Accepted
Guangxi Fenglin Wood Industry Group (601996.SH): Received tax matter notice requiring the payment of approximately 27 million yuan in taxes.

Zhejiang Yonghe Refrigerant (605020.SH) has had its application for the issuance of convertible bonds to unspecified recipients accepted by the Shanghai Stock Exchange.

CanSino Biologics Inc. (688185.SH): Application for Drug Registration of Adsorbed Acellular Combined Vaccine for Diphtheria, Tetanus, and Whooping Cough (Five Components) Accepted

RECOMMEND





